GLOFITAMAB
Clinical trials for GLOFITAMAB explained in plain language.
Never miss a new study
Get alerted when new GLOFITAMAB trials appear
Sign up with your email to follow new studies for GLOFITAMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to wipe out lingering cancer cells in aggressive lymphoma
Disease control Not yet recruitingThis study is testing if adding a drug called glofitamab after standard initial treatment can better control a fast-growing type of blood cancer called mantle cell lymphoma (MCL). It is for adults newly diagnosed with a high-risk form of MCL who have not yet started treatment. Th…
Matched conditions: GLOFITAMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Could your gut bugs predict cancer treatment success?
Knowledge-focused Not yet recruitingThis study aims to understand if the types of bacteria in a patient's gut (the microbiome) influence how well they respond to a lymphoma drug called glofitamab. Researchers will observe 30 patients with a specific type of lymphoma (DLBCL) who are already scheduled to receive this…
Matched conditions: GLOFITAMAB
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC